DOI:
10.1039/A907781B
(Paper)
Analyst, 2000,
125, 191-196
Determination of rare earth elements in human blood
serum by inductively coupled plasma mass spectrometry after chelating resin
preconcentration
Received 27th September 1999, Accepted 18th November 1999
First published on UnassignedUnassigned14th February 2000
Abstract
The determination of all rare earth elements (REEs) in human
blood serum by inductively coupled plasma mass spectrometry (ICP-MS) was
performed with the aid of chelating resin (Chelex 100) preconcentration
after acid digestion with HNO3 and HClO4. When
chelating resin preconcentration was carried out at room temperature, the
recoveries of heavy REEs were lower than those of light REEs because of
their stable complex formation with residual organic compounds remaining in
the digested serum solution. These problems were overcome by heating the
solution at 80 °C during the chelating resin preconcentration process.
As a result, the recoveries for all REEs were improved to 92–102% in
the case of a concentration factor of 4, where the analytical detection
limits for REEs were below 0.2 × 10−12 g
ml−1. Consequently, all REEs in individual human blood
sera collected from five healthy volunteers could be determined by ICP-MS
with good precision. The concentrations of REEs in human blood serum were
extremely low, in the range from ca. 1 ×
10−12 g ml−1 of Eu to ca. 230
× 10−12 g ml−1 of Ce.
Introduction
For the diagnosis of human health, disease and nutrition, trace and
ultra-trace elements in human blood serum have attracted great attention
and interest in medical and biological sciences.1–3 Among such trace elements, the biological and
physiological functions of the lanthanide or rare earth elements (REEs) are
not well known because of the lack of analytical data for biological
systems. In our modern society, REEs are widely used in applications such
as ceramics, semiconductors, magnets, magnetic resonance imaging (MRI)
contrast reagents, fertilizers and so forth.4–6 Hence large amounts of REEs are emitted in to the
environment, which may result in substantial exposure to humans. Therefore,
studies on REEs in human systems are one of the most interesting research
targets. In this context, analytical methods for the determination of REEs
in human blood serum should be established to determine their background
levels in the human body and to elucidate their physiological roles.Inductively coupled plasma mass spectrometry (ICP-MS) has the capability
for rapid multi-element detection over a wide concentration range with very
low detection limits.3 Therefore, ICP-MS has
been extensively applied to the analyses of biological materials and
fluids.7–10 In the determination of ultra-trace elements
in biological samples by ICP-MS, however, major constituents such as
organic compounds and inorganic salts cause matrix effects, which result in
signal suppression or enhancement, clogging of the sampling interface
orifices and spectral interference of polyatomic and doubly charged
ions.11,12 In addition, the
concentrations of REEs in biological samples are extremely low, so
efficient preconcentration of REEs and their separation from major
constituents are required for their accurate determination.
In a previous paper,13 we reported the
determination of all REEs in human blood serum reference material (NIES No.
4 issued by the National Institute for Environmental Studies, Tsukuba,
Japan) by ICP-MS, where the reference material was digested only with
nitric acid and REEs were preconcentrated by using a chelating resin
(Chelex 100) in a batch method. In the experiment, however, the recoveries
of REEs with chelating resin preconcentration were poor (67–80%). It
has been reported by several workers that incomplete digestion of
biological samples strongly influences the recoveries of analytes in
chemical separation processes.14–19 Pella et al. employed Chelex 100
separation for the determination of several trace elements in bovine liver
reference material (NIST SRM 1577), where the recovery of iron was
77%.14 Yang et al. reported that
some organic residues in the digested sample solutions lowered the
recoveries of specific elements (Cu, Zn) in solvent extraction with
ammonium pyrrolidinedithiocarbamate–chloroform.15,16 Martine and Schitt identified various organic
compounds in residues after digestion with HClO4.19 Their work indicated that amino acids derived
from proteins in biological samples could not be completely decomposed by
acid digestion. From these experimental results, it is considered that the
low recoveries of REEs in the Chelex 100 preconcentration might be caused
by poor adsorption of the REEs on the resin owing to the competitive
complex formation with residual organic compounds in the digested sample
solution. We therefore used HClO4 together with HNO3
for digestion to achieve better recoveries of REEs.20 As a result, the recoveries of REEs were
improved to 80–90%. However, there was still some influence on the
recoveries of REEs due to some residual organic compounds, and it was
impossible to determine all REEs in individual blood serum samples.
In this work, the experimental conditions such as pH, the amount of
chelating resin and temperature in chelating resin preconcentration were
further investigated to minimize the influences of residual organic
compounds in order to improve the recoveries of REEs. The analytical method
established here was then applied to the determination of REEs in the
individual human serum samples collected from five healthy volunteers.
Experimental
Instrumentation
A Model SPQ 8000A ICP-MS instrument (Seiko Instruments, Chiba, Japan),
which included a quadruple mass spectrometer, was used for the
determination of REEs. Matrix effects and instrumental drift in the ICP-MS
measurements were corrected by the internal standard method, where
103Rh (natural abundance 100%) and 187Re (62.6%) were
used as the internal standard elements. These elements were chosen as the
internal standard elements because they were not detected in blood serum
even after preconcentration and they did not cause any polyatomic ion
interferences with REEs. The internal standard correction was carried out
as described in a previous paper.21,22 The polyatomic interferences of oxide ions with Eu,
Gd, Tb, Yb and Lu were corrected by a mathematical correction method based
on a procedure similar to that of Vaughan and Horlick.23 An Plasma AtomComp MK II ICP-AES instrument
(Jarrell-Ash, Franklin, MA, USA) was also used for the determination of
major and some trace elements in blood serum samples, and was operated
under the usual conditions. The instrumental components and operating
conditions for the ICP-MS instrument are summarized in Table 1. pH measurements were performed with a
non-contact type compact pH meter (Model B-211, Horiba, Kyoto, Japan) to
avoid contamination from the electrode.
Table 1 Instrumental components and ICP-MS operating conditions
ICP-MS instrument | Model SPQ8000A from Seiko Instruments |
Plasma conditions— |
Rf frequency | 27.12 MHz |
Incident rf power | 1.0 kW |
Outer gas | Ar, 16 l min−1 |
Intermediate gas | Ar, 1.0 l min−1 |
Carrier gas | Ar, 1.0 l min−1 |
Sampling conditions— |
Sampling depth | 12 mm from work coil |
Sampling cone | Copper, orifice diameter 1.1 mm |
Skimmer cone | Copper, orifice diameter 0.35 mm |
Nebulizer | Glass concentric type (Meinhard
TR-30-C2) |
Sample uptake rate | 0.8 ml min−1 |
Data acquisition— |
Scanning mode | Peak hopping |
Data points | 3 points per peak |
Dwell time | 10 ms per point |
Integration | 100 times |
Chemicals
Multi-element standard solutions for ICP-MS measurement were prepared
from the commercially available single-element standard solutions (1000
μg ml
−1) for atomic absorption spectrometry (Wako Pure
Chemicals, Osaka, Japan). A stock standard solution of Re (1000 μg
ml−1) was prepared by dissolving the pure metal (99.99%)
(Nakalai Tesque, Kyoto, Japan) in 1 M HNO3. Ammonia, acetic acid
and hydrochloric acid were of electronics industry grade and nitric acid
and perchloric acid were of Ultrapur grade, all purchased from Kanto
Chemicals (Tokyo, Japan). Chelex 100 resin (sodium form, 200–400
mesh) was obtained from Bio-Rad Laboratories (Richmond, CA, USA). The resin
was cleaned before use by keeping it in 5 M hydrochloric acid for 5 d
(changed daily) and then washed with pure water and 2 M nitric acid in
turn. Pure water used throughout was prepared with a Milli-Q water
purification system (resistivity 18 MΩ cm) (Nihon Millipore Kogyo,
Tokyo, Japan).Human blood serum samples
Human blood samples were collected from five healthy university students
with a 30 ml polypropylene syringe equipped with a silicone-coated
stainless steel needle. These samples were transferred to silicone-coated
glass tubes and centrifuged at 3000 rpm for 20 min. The
supernatants were collected as the blood serum samples. Freeze-dried human
serum reference material (NIES No. 4) issued by the National Institute for
Environmental Studies was also used as a test sample in the preliminary
study.Digestion procedure for human blood serum
Blood serum samples were digested as follows. Blood serum (8 ml) was
placed in a Teflon beaker (100 ml) and after adding 2 ml of concentrated
HNO3 the serum sample was heated almost to dryness on a
hot-plate at 110 °C. Then 2 ml of concentrated HNO3 were
again added to the residue and the solution was heated at 150 °C for 2
h. After adding a further 2 ml of concentrated HNO3 and 1 ml of
60% HClO4, the solution was heated at 150 °C for 4 h until
white fumes appeared. This procedure was repeated twice. Finally, 0.76 ml
of concentrated HNO3 and ca. 1 ml of pure water were
added to dissolve the residue with heating at 110 °C for 1 h, and the
solution was diluted to 100 ml with pure water, then subjected to analysis
in the following experiment.The digestion procedure described above was carried out in a clean draft
(Yamato Science, Tokyo, Japan), and the evaporation process was performed
in an evaporation chamber system (San’ai, Nagoya, Japan), which was
composed of PFA sheet, three-piece PTFE drums, an infrared lamp (375 W) and
a clean air pump.24 Human blood serum
reference material was digested in a similar manner to that described
above.
Preconcentration procedure and recovery test
After acid digestion of human blood serum, REEs in the digested sample
solution were preconcentrated using Chelex 100 resin. The recommended
preconcentration procedure established after optimization was as follows.
First, 100 ml of the analysis solution were further diluted to 300 ml with
pure water. The pH of the solution was adjusted to 6 by adding acetic acid
solution and ammonia solution, and then the chelating resin (0.5 g) was
added to the diluted solution. After stirring the solution at 80 °C for
3 h, the resin was collected on a glass filter and rinsed carefully with 10
ml of 1 M ammonium acetate solution and 2 ml of pure water to remove Ca and
Mg adsorbed on the resin.25,26 Then,
REEs adsorbed on the chelating resin were eluted with 10 ml of 2 M
HNO3 solution. This eluted solution was evaporated to dryness in
the evaporation chamber and the residue was dissolved in 2 ml of 0.1 M
HNO3, which contained the internal standard elements Rh and Re
(10 ng ml−1 each). In the preconcentration procedure
employed here, the concentration factor for REEs in the final solution was
four (by volume), compared with the sample volume (8 ml) of the original
human blood serum.In the recovery test experiment, 5 ml of the multi-element standard
solution containing all REEs (1 ng ml−1 each) was added to
the digested solution of the human blood serum reference material (NIES No.
4) and the preconcentration procedure described above was carried out in
the same way. Then, REEs were determined by ICP-MS to obtain their
recoveries.
Results and discussion
In previous papers, we reported the determination of REEs in human blood
serum reference material13 and real blood serum samples20 by ICP-MS after chelating resin
preconcentration. As mentioned earlier, however, the recoveries of REEs in
the preconcentration procedure were poor. Therefore, the experimental
conditions such as pH, amount of chelating resin and temperature during the
preconcentration process were further investigated in detail in order to
obtain better recoveries of REEs in the chelating resin preconcentration.
In the following experiments, the digested solution of human blood serum
reference material (NIES No. 4) was used as the test solution.pH dependence of adsorption efficiencies of REEs in
chelating resin preconcentration
Since the adsorption efficiencies of REEs on the chelating resin are
generally influenced by the pH of the analysis solution, the pH dependence
of the recoveries of REEs in preconcentration was examined in the pH range
3–8. In this experiment, the test solution was prepared by adding 5
ml of 1 ng ml−1 each of all REEs to the digested solution
of human blood serum reference material. The preconcentration procedure at
the different pHs was then carried out at room temperature and the
concentrations of REEs in the preconcentrated test solution were determined
by ICP-MS. In Fig. 1, the pH dependence of
the recoveries for La, Tb and Yb is shown as typical examples of light,
medium and heavy REEs, respectively. In order to show the uncertainties of
the recovery values clearly, the error bars, which were estimated as the
standard deviations of triplicate experiments, are shown on each recovery
curve in Fig. 1. As can be seen, the
recoveries were almost constant or increased slightly from pH 3 to 6, then
decreased markedly above pH 6. These results were almost consistent with
those obtained for the chelating resin preconcentration of REEs in coastal
sea-water.26,27 Hence a pH of 6 was
adopted as the optimum in the subsequent chelating resin preconcentration.
It should be noted that the recoveries of La, Tb and Yb were significantly
different from each other, and that of Yb (heavy REE) was the lowest. |
| Fig. 1 pH dependence of recoveries of REEs in blood serum reference material in
chelating resin preconcentration, where 0.5 g of chelating resin was used.
●, La; ▲, Tb; ■, Yb. The test solution was prepared by
adding 5 ml of the multi-element standard solution containing all REEs to
give 50 pg ml−1 each in the digested solution of blood
serum reference material. | |
Effects of resin amounts and temperature on recoveries of
REEs in chelating resin preconcentration
It is well known that the recoveries of REEs depend on the amount of
resin used for preconcentration when the samples contain large amounts of
salts.26 Therefore, the dependence of the
recoveries of REEs on the resin amounts was examined by using the same test
solution as described above, where the pH of the analysis solution was
adjusted at 6. The experiment was carried out at 20 and 80 °C by adding
different amounts of the resin to the test solution. The results obtained
for Lu (heavy REE) is shown in Fig. 2. As
can be seen, a better recovery of Lu was obtained with an increase in the
amount of resin at both temperatures. It is also noticeable that the
recovery of Lu was much improved at 80 °C during the stirring
process. |
| Fig. 2 Dependence of recovery of lutetium on the amount of resin at different
temperatures in chelating resin preconcentration, where the pH was adjusted
at 6. ○, room temperature (ca. 20 °C); ●, 80
°C. Test solution as in Fig. 1. | |
Since high concentrations of Na, K, Mg and Ca cause matrix effects,
their concentrations in the preconcentrated test solution were determined
by ICP-AES after chelating resin preconcentration at 80 °C. Both Na and
K were removed at concentration levels less than 5 μg
ml−1, while the concentrations of Ca and Mg in the final
solution were 88.5 and 10.5 μg ml−1, respectively. The
concentrations of these elements were more than double those at 20 °C
(Ca 33.5, Mg 3.25 μg ml−1). The total amounts of the
major elements at 80 °C, however, were low enough to correct matrix
effects in the ICP-MS measurements by the internal standard method. Thus,
the higher temperature of 80 °C in the chelating resin preconcentration
was chosen because of the better recoveries of REEs. It can be seen from
Fig. 2 that the recovery of Lu is almost
constant above 0.5 g of the chelating resin at 80 °C. As a result, 0.5
g of the chelating resin and 80 °C in the preconcentration procedure
were employed as the optimum conditions in subsequent experiments.
Recoveries of REEs in chelating resin
preconcentration
The recoveries of REEs obtained by the digestion and preconcentration
methods mentioned above are summarized in Fig.
3, together with those in the previous experiments.13,20 As can be seen in Fig. 3, the recoveries of all REEs in the test
solution were significantly improved by using both HNO3 and
HClO4 in the digestion procedure, compared with those digested
only with HNO3. However, the recoveries of heavy REEs were still
lower than those of light REEs when the chelating resin preconcentration
was carried out at room temperature. These results suggest that some
residual organic compounds remaining in the digested solution have a large
influences on the adsorption of heavy REEs on the resin through complex
formation. Accordingly, the experimental fact that heavy REEs gave the
lower recoveries, as is seen in cases (A) and (B) in Fig. 3, may be explained by the competitive complex
formation of REEs between the chelating resin and the residual organic
species in the digested solution. |
| Fig. 3 Variation of recoveries of REEs obtained with different sample
pre-treatment procedures. ▲, HNO3 digestion and
preconcentration at room temperature;13
●, HNO3 + HClO4 digestion and preconcentration
at room temperature; 20
◆,
HNO3 + HClO4 digestion and preconcentration at 80
°C (this work). Test solution as in Fig.
1. | |
It can be clearly seen in Fig. 3 that the
recoveries of both heavy and medium REEs were markedly improved when the
solution was heated during the stirring process in chelating resin
preconcentration. These results indicate that the influence of residual
organic compounds on the preconcentration of REEs could be substantially
eliminated by heating the solution.
The recoveries of REEs obtained by the present method are summarized in
the first column of Table 2. It is seen that the recoveries of all REEs
were much improved in comparison with those in the previous reports,13,20 and they were in the range
92–102%. Under these conditions, the relative standard deviations of
the recovery values estimated from the triplicate experiments were less
than 2%, except for Ce (4.4%). These results indicate that the present
preconcentration procedure is reproducible enough to be applied to the
determination of REEs in human blood serum.
Analytical figures of merit
The analytical detection limits of REEs obtained in the present
experiment are summarized in Table 2. In
the estimation of the detection limits, first 10 ml of pure water were used
as a blank, being subjected to the same digestion and preconcentration
procedures as for human blood serum samples to obtain the analytical blank
solution. The obtained analytical blank solution was used for the
determination of the instrumental detection limits obtained as the
concentration corresponding to three times the standard deviation
(3ς) of the blank signal intensities, which was estimated from 10
repeated measurements of the analytical blank solution. The analytical
detection limits in Table 2 were then
calculated by dividing the instrumental detection limits by the
preconcentration factor 4, where the recoveries of REEs in the chelating
resin preconcentration were not corrected. As can be seen in Table 2, the analytical detection limits of all
REEs were at the sub-ppt level.
Table 2 Recoveries of REEs in chelating resin preconcentration and analytical
detection limits obtained by ICP-MS
Analytical |
---|
Recoverya | detection | Blank valueb |
---|
Element | m/z | (%) | limit/pg ml−1 | /pg ml−1 |
---|
All values are expressed as mean ±
s (n = 3).
The recoveries of REEs were estimated by using a digested solution of human
blood serum reference material (NIES No. 4) as the test solution. |
---|
All values are expressed as mean ±
s (n =
3). |
---|
La | 139 | 91.3 ± 1.7 | 0.07 | 22 ± 3 |
Ce | 140 | 92.7 ± 4.4 | 0.2 | 41 ± 11 |
Pr | 141 | 92.0 ± 1.7 | 0.04 | 4.5 ± 1.2 |
Nd | 146 | 91.0 ± 1.0 | 0.1 | 12 ± 2 |
Sm | 147 | 92.2 ± 1.7 | 0.2 | 2.4 ± 0.6 |
Eu | 151 | 92.6 ± 1.6 | 0.05 | 0.54 ± 0.16 |
Gd | 157 | 93.0 ± 1.2 | 0.2 | 2.2 ± 0.5 |
Tb | 159 | 93.8 ± 0.8 | 0.02 | 0.52 ± 0.10 |
Dy | 163 | 92.2 ± 1.3 | 0.1 | 2.1 ± 0.0 |
Ho | 165 | 93.1 ± 1.0 | 0.04 | 0.64 ± 0.03 |
Er | 166 | 101.9 ± 1.9 | 0.04 | 1.6 ± 0.2 |
Tm | 169 | 94.4 ± 1.1 | 0.03 | 0.29 ± 0.1 |
Yb | 174 | 93.5 ± 0.4 | 0.07 | 1.8 ± 0.1 |
Lu | 175 | 101.4 ± 1.0 | 0.03 | 0.38 ± 0.07 |
The blank values are given in the last column of Table 2. In the determination of the blank values,
10 ml of pure water were used as the test solution, and acid digestion,
chelating resin preconcentration and the ICP-MS measurement procedures were
carried out according to the proposed method. As can be seen in Table 2, the blank values were significantly
larger than the analytical detection limits. As will be mentioned later,
however, these blank values were fortunately lower than the concentrations
of REEs in blood serum. The sources of the blank were also examined with
the aim of decreasing the blank level in the present experimental
procedure, but the blank sources could not be elucidated at the present
blank level.
Determination of REEs in human blood serum
In pilot work, the concentrations of REEs in human blood serum reference
material (NIES No. 4) were determined by ICP-MS after acid digestion and
chelating resin preconcentration as developed in the present experiment.
The results are summarized in Table 3,
together with those reported in the previous paper.13 The blank values in Table 2 were subtracted from the measured values
to obtain the observed values for REEs. As can be seen from the comparison
of the results in Tables 2 and 3, the concentrations of all REEs obtained in the
present experiment were considerably higher than their analytical detection
limits. The analytical values for blood serum reference material were also
at least 10 times larger than the blank values, which is shown in Table 2. In the previous work, the analytical
values for blood serum reference material were corrected by using the
recovery of each element because of the low recovery in the chelating resin
preconcentration.13 However, such a
correction was not made for the analytical values obtained in the present
experiment because the recoveries in preconcentration were 92–102%,
being much improved. Even so, the analytical values for REEs obtained here
were at almost the same levels as those in the previous experiment.
Furthermore, as can be seen in Table 3,
the standard deviations of the analytical values (n = 3),
especially for light REEs, were significantly smaller than the previous
ones. Hence it is considered that the analytical values for human blood
serum reference material in the present experiment are more reliable than
those in the previous experiment.
Table 3 Concentrations of REEs in human blood serum reference material (NIES No.
4) determined by ICP-MS after chelating resin preconcentration
Element | Observed valuea/pg ml−1 | Literature value12 |
---|
All values are expressed as mean ±
s (n = 3).
|
---|
Average (n = 2). |
---|
La | 209 ± 1 | 206 ± 20 |
Ce | 419 ± 12 | 440 ± 72 |
Pr | 45.6 ± 0.7 | 42.3 ± 5.2 |
Nd | 169 ± 5 | 171 ± 18 |
Sm | 41.1 ± 3.4 | 35.9 ± 2.5 |
Eu | 3.52 ± 0.85 | 3.1b |
Gd | 41.0 ± 3.7 | 46.5 ± 1.0 |
Tb | 5.99 ± 0.42 | 7.3 ± 0.8 |
Dy | 40.9 ± 3.8 | 43.2 ± 6.2 |
Ho | 8.53 ± 1.11 | 10.2 ± 0.6 |
Er | 33.7± 5.0 | 31.2 ± 1.8 |
Tm | 5.75 ± 1.03 | 5.1 ± 0.4 |
Yb | 38.6 ± 4.2 | 44.7 ± 8.7 |
Lu | 6.62 ± 0.90 | 5.6b |
The analytical results for the individual human blood serum samples
collected from five healthy volunteers (four male students and one female
student) are presented in Table 4. In
the last column, the average values of REEs for five specimens are also
shown together with their relative standard deviations (RSDs) in
parentheses. It can be seen that REEs in human blood serum from individual
persons were extremely low with a wide concentration range from 8.2 ×
10−13 g ml−1 of Eu to 2.14 ×
10−10 g ml−1 of Ce on average. It should
be noted that RSDs of the analytical values for REEs in five specimens were
within 25%, even though their concentrations were extremely low. These
results suggest that the concentrations of REEs in the individual human
blood serum samples are maintained at an almost constant level under the
homeostasis mechanism of the biological system. In addition, all REEs in
the real serum samples were at lower concentration levels than those in the
human blood serum reference material (NIES No. 4). The higher
concentrations of REEs in the reference material might have been caused by
the contamination of REEs during its preparation. It can also be seen from
the data in Tables 2 and 4 that the concentrations of REEs in blood serum
were four or more times higher than the blank values, but the analytical
values for some of medium and heavy REEs in blood serum were much lower
than those for light REEs. Therefore, such medium and heavy REEs might not
be determined if the chelating resin preconcentration is not improved, as
mentioned earlier.
Table 4 Concentrations of REEs in the individual human serum samples determined
by ICP-MS after chelating resin preconcentration
Concentrationa/pg ml−1 |
---|
Element | Atomic number | A | B | C | D | E | Average valueb/pg ml−1 | RSD (%) |
---|
A–E indicate five individual persons who donated the blood samples
for the present experiment. |
---|
Average values of the data for A–E. |
---|
La | 57 | 73.2 | 58.6 | 66.8 | 56.0 | 59.0 | 62.7 ± 7.1 | 11.4 |
Ce | 58 | 235 | 187 | 235 | 195 | 216 | 214 ± 22 | 10.4 |
Pr | 59 | 13.5 | 10.0 | 11.4 | 9.6 | 10.9 | 11.1 ± 1.5 | 13.9 |
Nd | 60 | 39.8 | 31.6 | 35.4 | 28.4 | 33.5 | 33.7 ± 4.2 | 12.6 |
Sm | 62 | 7.4 | 4.6 | 6.2 | 5.1 | 5.5 | 5.8 ± 1.1 | 18.8 |
Eu | 63 | 1.08 | 0.67 | 0.99 | 0.66 | 0.72 | 0.82 ± 0.19 | 23.6 |
Gd | 64 | 8.6 | 6.0 | 7.0 | 5.8 | 8.7 | 7.2 ± 1.4 | 19.0 |
Tb | 65 | 1.64 | 1.11 | 1.15 | 1.23 | 1.43 | 1.30 ± 0.22 | 17.2 |
Dy | 66 | 11.2 | 8.9 | 8.8 | 8.8 | 10.3 | 9.6 ± 1.1 | 11.2 |
Ho | 67 | 3.44 | 2.20 | 2.15 | 2.34 | 2.83 | 2.55 ± 0.54 | 21.1 |
Er | 68 | 12.4 | 8.3 | 7.8 | 8.7 | 10.3 | 9.5 ± 1.9 | 19.9 |
Tm | 69 | 2.34 | 1.35 | 1.45 | 1.67 | 1.86 | 1.69 ± 0.42 | 24.9 |
Yb | 70 | 17.8 | 11.3 | 10.4 | 11.4 | 15.4 | 13.2 ± 3.2 | 24.1 |
Lu | 71 | 3.11 | 2.15 | 1.92 | 2.15 | 3.11 | 2.46 ± 0.58 | 23.7 |
According to the Oddo–Harkins rule,28 in general the abundance of an element with an
even atomic number is larger than those of neighboring elements with odd
atomic numbers. It can be seen in Table
4 that the Oddo–Harkins rule holds in the case of REEs in
human blood serum. These facts indicate that some special mass selection
does not occur for REEs in blood serum.
Comparison of the distribution patterns of REEs in human
blood serum, sea-water and bovine whole blood
The concentration distribution patterns of REEs in human blood serum
determined in the present study are shown in Fig.
4, together with the patterns for human blood reference material
(Table 3), coastal sea-water,26 open sea-water29
and bovine whole blood,30 where the
concentrations of REEs were normalized by those in a Post-Archean Average
Australian Shale.31 Such a normalized
distribution pattern of REEs is often referred to as the ‘REE
pattern’. Although the Leedey chondrite-normalized REE pattern32,33 is mostly used in geological and
geochemical studies, the REE abundances of shale, which are considered to
represent the REE abundances of the continental crust, are popularly used
for the normalization in the marine geochemistry. Hence the REE abundances
of the Post-Archean Average Australian Shale31 were employed here for normalization. In Fig. 4, the average values of the REE concentrations
for five persons presented in Table 4
were taken as the values for human blood serum. We also tried to determine
REEs in human whole blood by a similar method to that proposed here, but
the determination of REEs in whole blood has not been successful so far.
Therefore, the REE concentrations in bovine whole blood were used in
Fig. 4 for comparison, as reported in our
previous paper.30 |
| Fig. 4 Post-Archean Average Australian Shale-normalized REE patterns for human
blood serum, sea-water and bovine whole blood. □, human blood serum
reference material (NIES No. 4) (this work); ■, human blood serum
(average concentrations in Table 4);
○, coastal sea-water (Nagoya port);26
●, open sea-water (north Pacific Ocean);29▲, bovine whole blood (IAEA A-13).30 | |
It should be stressed that the REE pattern of human blood serum and
those of coastal and open sea-waters are very similar to each other,
although the concentrations of REEs in blood serum are markedly higher than
those in coastal and open sea-waters. In contrast, since the concentrations
of heavy REEs in bovine whole blood are very low, the REE pattern of bovine
whole blood is different from that of human blood serum. It is often
suggested that the origin of life on Earth might have occurred in the sea
because the compositions of the elements in human blood and sea-water are
similar to each other.34 If it were
believed, the similarities of the REE patterns for blood serum and
sea-water, shown in Fig. 4, might lead to
the hypothesis that the homeostasis mechanism for REEs has been maintained
in human blood serum since the origin of life in the sea. Further study is,
of course, necessary to prove such a hypothesis for the origin of life.
Even so, we consider that the concentration distribution patterns of REEs
in biological systems might be one of the keys to solving the puzzle of the
origin of life.
It is also noted that clear negative anomalies are found for Ce in the
case of both coastal and open sea-waters and a small negative anomaly for
Eu in the case of coastal sea-water. In contrast, in the case of human
blood serum, a small negative anomaly was observed only for Eu, and a small
positive anomaly was observed for Ce, as can be seen in Fig. 4. REEs usually exist with a valency of +3.
However, Ce and Eu can have two different valencies, +3 and +4 for the
former and +2 and +3 for the latter, under different redox conditions.
Therefore, Ce and Eu in bio-geochemical samples often provide different
distributions from other REEs, which results in the anomalies in the REE
pattern. The small positive and negative anomalies for Ce and Eu observed
for human blood serum, shown in Fig. 4,
suggest that the degrees of the higher (+4) and lower (+2) valencies of Ce
and Eu, respectively, with respect to the normal valencies (+3) in blood
serum are different from those in sea-water, reflecting the different redox
conditions in serum and sea-water.
Conclusion
The concentrations of all REEs in human blood serum were determined on
an individual basis by ICP-MS after acid digestion and chelating resin
preconcentration. Because of the limited sample amount (volume) of blood
serum available for analysis, it was very important to perform efficient
preconcentration of REEs to obtain accurate and reliable data. Since the
residual organic compounds in the digested solution possibly have a great
influence on the recoveries of REEs in chelating resin preconcentration,
complete decomposition of the blood serum sample is also desirable for
efficient preconcentration of REEs. Further investigations on the
concentration distributions of REEs in blood serum and whole blood and also
other biological organs are required to elucidate their physiological roles
in the biological systems. Such work might help in solving the puzzle of
the origin of life in the sea.Acknowledgement
Thet authors express their sincere thanks to the late Professor Shigeo
Takeuchi of Nihon University School of Medicine for his help in obtaining
the blood serum samples.References
- G. V. Iyengar,
Elemental Analysis of Biological Systems, CRC
Press, Boca Raton, FL,
1989. Search PubMed.
- J. Versieck and
R. Cornelis,
Trace Elements in Human Plasma or Serum, CRC
Press, Boca Raton, FL,
1989. Search PubMed.
- H. Haraguchi, Bull. Chem. Soc. Jpn., 1999, 72, 1163 CrossRef CAS.
- L. Liang, P. C. D’Haese, L. V. Lamberts, F. L. Van de Vyver and E. De Bore, Anal. Chem., 1991, 63, 423 CrossRef CAS.
- A. V. Gorbunov, M. V. Frontasyeva, S. F. Gundorina, T. L. Onischenko, B. B. Maksjuta and C. S. Pal, Sci. Total Environ., 1992, 122, 337 CrossRef CAS.
- E. Diatloff, F. W. Smith and C. J. Asher, J. Plant Nutr., 1995, 18, 1991 Search PubMed.
- H. Vanhoe, R. Dams and J. Versieck, J. Anal. At. Spectrom., 1994, 9, 23 RSC.
- A. Taylor, S. Branch, H. M. Crews, D. J. Halls and M. White, J. Anal. At. Spectrom., 1997, 12, 119R Search PubMed.
- A. Taylor, S. Branch, D. J. Halls, L. M. W. Owen and M. White, J. Anal. At. Spectrom., 1998, 13, 57R RSC.
- H. Haraguchi,
E. Fujimori and
K. Inagaki, in
Free Radical and Antioxidant Protocols, ed. D. Armstrong,
Humana Press, Totowa, NJ,
1998, 389-411. Search PubMed.
- K. E. Jarvis,
A. L. Gray and
R. S. Houk,
Handbook of Inductively Coupled Plasma Mass Spectrometry,
Chapman and Hall, New York,
1992. Search PubMed.
- Inductively Coupled Plasmas Mass Spectrometry, ed. A.
Montaser, Wiley-VCH, New York,
1998. Search PubMed.
- E. Fujimori, Y. Tomosue and H. Haraguchi, Tohoku J. Exp. Med., 1996, 178, 63 Search PubMed.
- P. A. Pella, H. M. Kingston and J. R. Sleber, Anal. Chem., 1983, 55, 1193 CAS.
- J. Y. Yang, M. H. Yang and S. M. Lin, Anal. Chem., 1985, 57, 472 CrossRef CAS.
- J. Y. Yang, M. H. Yang and S. M. Lin, Anal. Chem., 1990, 62, 146 CrossRef CAS.
- J. W. Jones, G. Capar and T. C. O’Haver, Analyst, 1982, 107, 353 RSC.
- J. W. Jones and T. C. O’Haver, Spectrochim. Acta, Part B, 1985, 40, 263 CrossRef.
- G. D. Martine and A. A. Schitt, Anal. Chem., 1976, 48, 70 CrossRef.
- K. Inagaki and H. Haraguchi, Chem. Lett., 1997, 8, 775 CrossRef.
- H. Sawatari, E. Fujimori and H. Haraguchi, Anal. Sci., 1995, 11, 369 Search PubMed.
- W. Doherty, Spectrochim. Acta, Part B, 1989, 44, 263 CrossRef.
- M. A. Vaughan and G. Horlick, Appl. Spectrosc., 1990, 44, 587 Search PubMed.
- H. Isoyama, T. Uchida, K. Oguchi, C. Iida and G. Nakagawa, Anal. Sci., 1990, 6, 385 Search PubMed.
- H. M. Kingston, I. L. Barnes, T. J. Brady, T. C. Rains and M. A. Champ, Anal. Chem., 1978, 50, 2064 CrossRef CAS.
- H. Sawatari, T. Toda, T. Saizuka, C. Kimata, A. Ito and H. Haraguchi, Bull. Chem. Soc. Jpn., 1995, 68, 3065 CAS.
- T. Yabutani, J. Shan, F. Mouri, A. Itoh, H. Sawatari, K. Chiba and H. Haraguchi, Bull. Chem. Soc. Jpn, 1999, 72, 2253 CAS.
- P. K. Kuroda,
The Origin of the Chemical Elements and the Oklo Phenomenon,
Springer-Verlag, Berlin,
1982. Search PubMed.
- J. Zhang and Y. Nozaki, Geochim. Cosmochim. Acta, 1996, 60, 4631 CrossRef CAS.
- E. Fujimori, T. Hayashi, K. Inagaki and H. Haraguchi, Fresenius’ J. Anal. Chem., 1999, 363, 277 CrossRef CAS.
- S. M. McLeman, in
Geochemistry and Mineralogy of Rare Earth Elements, ed. B.
R. Lipin and G. A. McKay, Mineralogy Society of America,
Washington, DC, 1989, pp.
169-200. Search PubMed.
- C. D. Coryell, J. W. Chase and J. W. Winchester, J. Geophys. Res., 1963, 68, 559 CAS.
- A. Masuda and Y. Matsui, Geochim. Cosmochim. Acta, 1966, 30, 239 CrossRef CAS.
- A. M. Fiabane and
D. R. William,
The Principles of Bio-inorganic Chemistry,Royal
Society of Chemistry, London,
1981. Search PubMed.
|
This journal is © The Royal Society of Chemistry 2000 |
Click here to see how this site uses Cookies. View our privacy policy here.